跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Esmo-IV - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Esmo-IV
Approved
STANDARD
Esmo-IV
Myungmoon Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9c6ec4b9a793c331
Company
Myungmoon Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
9c6ec4b9a793c331
Drug Approval Philippines Name
Esmo-IV
Product Name
Esmo-IV
Registration Number
DR-XY48043
Brand Name
Esmo-IV
Generic Name
Esmolol hydrochloride
Dosage Form
Solution for Injection (IV)
Dosage Strength
10 mg/mL
Manufacturer
Myungmoon Pharmaceutical Co., Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
26 May 2022
Expiry Date
26 May 2027
Pharmacologic Category
Beta Adrenoceptor Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9c6ec4b9a793c331
Type
Standard
Back to Philippines FDA Approvals